Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – As a tocolytic agent to aid external cephalic version, the calcium antagonist nifedipine doesn’t seem to work very well, according to a systematic…
NEW YORK (Reuters Health) – Placement of an indwelling catheter in the bladder before cesarean section is a long-standing practice that is “not justified by research evidence,” clinicians…
NEW YORK (Reuters Health) – Tinidazole is no more effective than metronidazole in bacterial vaginosis. New treatments are still needed, researchers report in an on-line paper in the…
NEW YORK (Reuters Health) – Pregnant women and pediatric patients with inflammatory bowel disease (IBD) should be treated with biological therapy to induce and maintain remission, according to…
NEW YORK (Reuters Health) – Active management of the third stage of labor leads to less blood loss compared to expectant management, without altering the childbirth experience, a…
NEW YORK (Reuters Health) – Vaginal misoprostol applied prior to intrauterine device (IUD) insertion does not make the procedure go any easier or lessen the patient’s pain, a…
NEW YORK (Reuters Health) – Women with latent celiac disease — positive celiac antibodies but a normal small bowel biopsy — may be at increased risk of reproductive…
NEW YORK (Reuters Health) – Intrapartum translabial ultrasound (ITU) appears to be an effective way to monitor birth progress in term fetuses in cephalic presentation, researchers reported online…
NEW YORK (Reuters Health) – Office-based endometrial ablation for menorrhagia is equally effective with thermal balloon ablation or bipolar radiofrequency, U.K. researchers say. Six months after randomization and…
